首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1800179

血管移植市場：2025-2030 年預測

Vascular Graft Market - Forecasts fom 2025 to 2030

出版日期: 2025年08月18日 | 出版商:

Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

血管移植市場預計將從 2025 年的 15.79 億美元成長到 2030 年的 20.38 億美元，複合年成長率為 5.23%。

全球血管移植市場正在經歷顯著成長，這主要歸因於慢性腎臟病(CKD) 盛行率的上升以及心臟病等心血管疾病發病率的上升。這些疾病需要透析和冠狀動脈繞道手術手術 (CABG) 等先進的外科手術干預，而這些手術嚴重依賴血管移植來恢復或維持重要的血流。隨著這些疾病在全球範圍內的負擔加重，對可靠有效的血管移植的需求將持續成長，從而有望推動市場持續成長。

主要成長要素

心臟病發作的發生率增加

心臟病和中風的盛行率不斷上升是推動血管移植市場發展的主要因素。冠狀動脈疾病和使用微血管瓣重組等疾病需要進行冠狀動脈繞道手術（CABG）等手術，而CABG是全球最常見的心血管手術之一。這些手術需求的不斷成長推動了對血管移植的需求，而血管移植對於繞過阻塞的動脈並恢復血流至關重要。中風發生率的上升也進一步推動了對先進心血管設備的需求，因為這些疾病通常需要結合血管移植的手術方案來確保有效的治療效果。

慢性腎臟病增加

慢性腎臟病（CKD）通常會發展為末期腎功能衰竭（ESRD），是血管移植市場的主要驅動力。 ESRD患者通常需要血液透析機，而血液透析則依賴可靠的血管網路基地台，例如動靜脈瘻管（AVF）和動靜脈移植物（AVG）。血管移植物在創建和維護這些網路基地台發揮關鍵作用，確保透析期間血液的有效過濾。隨著全球慢性腎臟病（CKD）的增多，血液透析機的需求也在不斷成長，從而推動了市場的擴張。

地理視角

美國作為主要市場

預計美國將成為預測期內規模最大、成長最快的血管移植市場。人口老化是推動這一成長的動力，這增加了動脈粥狀硬化、冠狀動脈疾病、周邊動脈疾病和動脈瘤等血管疾病的風險。這些疾病通常需要外科手術干預，例如搭橋手術或動脈瘤修復，而這些手術依賴血管移植來恢復血流。這些疾病的盛行率不斷上升，加上先進的醫療基礎設施和對創新醫療解決方案的關注，使美國成為血管移植應用的主要市場。

受慢性腎臟病和心血管疾病（尤其是心臟病）發病率上升的推動，全球血管移植市場預計將強勁成長。透析和冠狀動脈繞道手術（CABG）等外科手術的需求不斷成長，凸顯了血管移植在現代醫療保健中的關鍵作用。市場擴張由美國主導，美國人口老化，血管疾病發生率高，導致需求持續成長。隨著醫療保健系統應對這些日益嚴峻的挑戰，血管移植在改善患者預後和支持關鍵醫療程序方面仍將發揮重要作用。

本報告的主要優點

深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
競爭格局：了解主要企業採用的策略策略，並了解正確策略的市場滲透潛力。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力進行策略決策並在動態環境中開闢新的業務流和收益。
受眾範圍廣：對於新興企業、研究機構、顧問、中小企業和大型企業來說都是有益且具成本效益的。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

調查範圍

2020 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
競爭定位、策略和市場佔有率分析
收益成長和預測細分市場和區域分析（包括國家）
公司概況（尤其是趨勢）、財務資訊和關鍵發展

介紹
北美洲
- 按來源
- 按指示
- 按最終用戶
- 按國家
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 按來源
- 按指示
- 按最終用戶
- 按國家
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 按來源
- 按指示
- 按最終用戶
- 按國家
  - 英國
  - 法國
  - 德國
  - 義大利
  - 其他
中東和非洲
- 按來源
- 按指示
- 按最終用戶
- 按國家
  - 沙烏地阿拉伯
  - 以色列
  - 其他
亞太地區
- 按來源
- 按指示
- 按最終用戶
- 按國家
  - 日本
  - 中國
  - 印度
  - 澳洲
  - 韓國
  - 泰國
  - 台灣
  - 印尼
  - 其他

第9章：競爭格局及分析

主要企業和策略分析
新興企業和市場盈利
市場佔有率分析
供應商競爭力矩陣

第10章：公司簡介

Getinge Group
WL Gore & Associates
B. Braun Melsungen AG
LeMaitre Vascular Inc.
Abbott Laboratories
Cook Medical
Terumo Medical Corporation
Cryolife
Medtronic PLC
Endologix Inc.

簡介目錄

Product Code: KSI061611564

The vascular graft market is expected to grow from USD 1.579 billion in 2025 to USD 2.038 billion in 2030, at a CAGR of 5.23%.

The global vascular graft market is experiencing significant growth, primarily driven by the rising prevalence of chronic kidney disease (CKD) and the increasing incidence of cardiovascular conditions, such as heart strokes. These health challenges necessitate advanced surgical interventions, including dialysis and coronary artery bypass grafting (CABG), which rely heavily on vascular grafts to restore or maintain critical blood flow. As the global burden of these diseases grows, the demand for reliable and effective vascular grafts continues to expand, positioning the market for sustained growth.

Key Growth Drivers

Rising Incidence of Heart Strokes

The increasing prevalence of heart disease and strokes is a major factor propelling the vascular graft market. Conditions such as coronary artery disease and microvascular flap-based reconstructions require procedures like CABG, which is among the most common cardiac surgeries globally. The growing need for these interventions drives demand for vascular grafts, which are essential for bypassing blocked arteries and restoring blood flow. The rising incidence of strokes further amplifies the need for advanced cardiovascular devices, as these conditions often necessitate surgical solutions that incorporate vascular grafts to ensure effective treatment outcomes.

Growing Prevalence of Chronic Kidney Disease

Chronic kidney disease, often progressing to end-stage renal disease (ESRD), is a significant driver of the vascular graft market. ESRD patients frequently require hemodialysis, which depends on reliable vascular access points such as arteriovenous fistulas (AVFs) or arteriovenous grafts (AVGs). Vascular grafts play a critical role in creating and maintaining these access points, enabling efficient blood filtration during dialysis. As the global incidence of CKD rises, the demand for vascular grafts to support hemodialysis continues to grow, further fueling market expansion.

Geographical Outlook

United States as a Leading Market

The United States is anticipated to be the largest and fastest-growing market for vascular grafts during the forecast period. This growth is driven by an aging population, which faces an elevated risk of vascular diseases such as atherosclerosis, coronary artery disease, peripheral artery disease, and aneurysms. These conditions often require surgical interventions, including bypass procedures and aneurysm repairs, which rely on vascular grafts to restore blood flow. The increasing prevalence of these health issues, combined with advanced healthcare infrastructure and a focus on innovative medical solutions, positions the U.S. as a key market for vascular graft adoption.

The global vascular graft market is poised for robust growth, driven by the rising prevalence of chronic kidney disease and cardiovascular conditions, particularly heart strokes. The increasing demand for dialysis and surgical interventions like CABG underscores the critical role of vascular grafts in modern healthcare. With the United States leading market expansion due to its aging population and high incidence of vascular diseases, the vascular graft market is expected to see sustained demand. As healthcare systems address these growing challenges, vascular grafts will remain essential in improving patient outcomes and supporting critical medical procedures.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2020 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Source

Synthetic
Semi-Synthetic
Natural

By Indication

Cardiovascular
Renal Disease
Aneurysms
Others

By End-User

Hospital & Clinics
Ambulatory Surgical Centers

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Taiwan
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY SOURCE

5.1. Introduction
5.2. Synthetic
5.3. Semi-Synthetic
5.4. Natural

6. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY INDICATION

6.1. Introduction
6.2. Cardiovascular
6.3. Renal Disease
6.4. Aneurysms
6.5. Others

7. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY END-USER

7.1. Introduction
7.2. Hospital & Clinics
7.3. Ambulatory Surgical Centers

8. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Source
- 8.2.2. By Indication
- 8.2.3. By End-User
- 8.2.4. By Country
  - 8.2.4.1. United States
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Source
- 8.3.2. By Indication
- 8.3.3. By End-User
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Source
- 8.4.2. By Indication
- 8.4.3. By End-User
- 8.4.4. By Country
  - 8.4.4.1. UK
  - 8.4.4.2. France
  - 8.4.4.3. Germany
  - 8.4.4.4. Italy
  - 8.4.4.5. Others
8.5. Middle East and Africa
- 8.5.1. By Source
- 8.5.2. By Indication
- 8.5.3. By End-User
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. Israel
  - 8.5.4.3. Others
8.6. Asia Pacific
- 8.6.1. By Source
- 8.6.2. By Indication
- 8.6.3. By End-User
- 8.6.4. By Country
  - 8.6.4.1. Japan
  - 8.6.4.2. China
  - 8.6.4.3. India
  - 8.6.4.4. Australia
  - 8.6.4.5. South Korea
  - 8.6.4.6. Thailand
  - 8.6.4.7. Taiwan
  - 8.6.4.8. Indonesia
  - 8.6.4.9. Others